Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 3

1.

Comparison of methodologies to define hemodialysis patients hyporesponsive to epoetin and impact on counts and characteristics.

Gilbertson DT, Peng Y, Arneson TJ, Dunning S, Collins AJ.

BMC Nephrol. 2013 Feb 20;14:44. doi: 10.1186/1471-2369-14-44.

2.

Dosing patterns, drug costs, and hematologic outcome in anemic patients with chronic kidney disease switching from darbepoetin alfa to epoetin alfa.

Hymes J, Bickimer T, Jackson JH, Bookhart BK, Mody SH, Tak Piech C.

Curr Med Res Opin. 2007 Aug;23(8):1931-7. Review.

PMID:
17624232
3.

Managing dialysis patients who develop anemia caused by chronic kidney disease: focus on peginesatide.

Valliant A, Hofmann RM.

Int J Nanomedicine. 2013;8:3297-307. doi: 10.2147/IJN.S44944. Epub 2013 Aug 26. Review.

Supplemental Content

Support Center